Stop Using E25Bio COVID-19 Antigen Tests, FDA Says
Executive Summary
The US FDA is asking health care providers and the public to cease using the E25Bio COVID-19 Direct Antigen Rapid Test because the agency is concerned about the diagnostic giving false results. The FDA is also worried that people could injure themselves when self-collecting a sample from the nose or throat.